1WHO.Report on the Consultation on Establishing Regional Guidelines on Osteoporosis[M].Beirut Lebanon,2004:5.
2Osteoporosis Prevention,Diagnosis,and Therapy.NIH Consensus Development Panel on Osteoporosis Prevention,Diagnosis,and Therapy[J].JAMA,2001,285:785-795.
3Heap J,Murray MA,Miller SC,et al.Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus[J].2004,144(1):56-62.
4Akin O,Gol K,Akturk M,et al.Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements[J].Gynecol Endocrinol,2003,17(1):19-29.
5Balint E,Szabo P,Marshall CF,et al.Glucose-induced inhibition of in vitro bone mineralization[J].Bone,2001,28(1):21-8.
9Huafei Lu,Douglas Kraut,Louis C,et al.Graves.Diabetes Interferes with the Bone Formation by Affecting the Expression of Transcription Factors that Regulate Osteoblast Differentiation[J].Endocrinology,2003,144(1):346-352.
2[3]UK prospective diabetes study group.Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type Ⅱ diabetes (UKPDS33)[J]. Lancet,1998,352:837
3[7]Linda K, Richard LB, Braxton DM. Type Ⅱ diabetes and insulin levels are associated with bone mineral density in Mexican American women[J]. Diabetes,2000,49:Supplement 1 A192
4While MF. The insulin signalling system and the IRS proteins. Diabetologia,1997,40 Suppl 2: S2-S17.
5Kubota N,Tobe K,Terauchi Y,et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes, 2000, 49:1880-1889.
6Ogata N, Chikazu D, Kubota N,et al. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest, 2000,105:935-943.
7Akune T, Ogata N, Hoshi K,et al. Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol, 2002,159:147-156.
8Stein GS, Lian JB. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev, 1993, 14: 424-442.
9Hirashima Y, Tsuruzoe K, Kodama S, et al. Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway. J Endocrinol, 2003,179: 253-266.
10Giguere Y, Rousseau F. The genetics of osteoporosis: complexities and difficulties. Clin Genet 2000;57(3): 161-9
1Adami S,Braga V,Zamboni M,et al.Relationship between lipids and bone mass in two cohorts of healthy women and men[J].Calcif Tissue Int,2004;74(2):136-42.
2Samelson EJ,Cupples LA,Hannan MT,et al.Long-term effects of serum cholesterol on bone mineral density in women and men:the Framingham Osteoporosis Study[J].Bone,2004;34(3):557-61.
3Yamaguchi T,Sugimoto T,Yano S,et al.Plasma lipids and osteoporosis in postmenopausal women[J].Endocrinology,2002;49(2):211-7.
4中华医学会糖尿病学分会.中国2型糖尿病防治指南[M].北京:北京大学医学出版社,2010:70.
5Lau EM, Leung PC, Kwok T, et al . The determinants of bone mineral density in Chinese men - results from Mr. Os ( Hong Kong) , the first cohort study on osteoporosis in Asian men[J]. Ost Eoporos Int, 2005,17(2) : 297-303.
